#OSRH

OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries OSR Holdings (NASDAQ:OSRH) completed the acquisition of Woori IO, effective January 26, 2026, making Woori IO a consolidated subsidiary and strengthening OSRH's noninvasive glucose monitoring and wearable health capabilities.Legacy shareholders of Woori IO agreed to a three-year equity alignment to exchange OSR Holdings Co., Ltd. (OSRK) interests into NASDAQ-listed OSRH common stock only at a USD $10.00 per share reference price, intended to limit near-term dilution. OSRH also initiated a strategic review to potentially combine its medical device subsidiaries, Woori IO and RMC, to form an integrated medical technology and distribution company and evaluate a possible standalone IPO in Korea, subject to market, regulatory, and board approvals.

1 month ago

#OSRH OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries

www.stocktitan.net/news/OSRH/osr-holdings-c...

0 0 0 0

Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch Woori IO (OSR Holdings, ticker OSRH) said the FDA clarified that consumer wearable products giving non-medical, wellness-oriented health insights—if properly labeled and marketed—generally fall outside medical-device pre-market review. Woori IO plans a two-phase commercialization: Phase 1 consumer-grade wellness wearables to accelerate time-to-market and gather real-world data; Phase 2 medical-grade CGM solutions pursued through appropriate regulatory pathways. The company cited collaboration plans with Samsung-related smartwatch platforms and said OSR Holdings expects to complete a previously announced share exchange with Woori IO on January 26, 2026.

1 month ago

#OSRH Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch

www.stocktitan.net/news/OSRH/woori-io-an-os...

0 0 0 0

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings Company advancing dual clinical pathways, including a Samsung-supported PoC trial in Korea and a planned U.S. FDA trial with a leading California research university. With the corporate combination now finalized, Woori IO also plans to initiate U.S. market development activities, supported by an invitation from a prestigious research university to...

2 months ago

#OSRH Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

www.stocktitan.net/news/OSRH/woori-io-share...

0 0 0 0

Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months OSR Holdings (NASDAQ: OSRH) subsidiary Vaximm AG updated a non-binding term sheet with BCM Europe AG to shorten the exclusivity period from six months to three months, with the parties aiming to finalize a definitive exclusive global licensing agreement for VXM01 within that three-month window ending February 2026. The contemplated financial terms remain unchanged: a $20 million upfront payment, up to $815 million in clinical, regulatory, and commercial milestone payments, and a pass-through of commercial royalties via a defined delta-recovery mechanism. Vaximm retains IP ownership of VXM01 until a definitive license is executed. The term sheet also preserves an optional blockchain-based royalty participation mechanism using TAC tokens.

3 months ago

#OSRH Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months

www.stocktitan.net/news/OSRH/vaximm-ag-an-o...

0 0 0 0

Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones Vaximm (NASDAQ:OSRH) entered a non-binding term sheet with BCM Europe AG on Nov 21, 2025 to negotiate an exclusive global license for VXM01, Vaximm's oral cancer immunotherapy.Under the contemplated terms Vaximm would receive a $20 million upfront payment, up to $815 million in clinical, regulatory and commercial milestones, and a pass-through of commercial royalties BCME may receive after a defined delta-recovery. The term sheet sets a six-month exclusivity window, is subject to due diligence and board approvals, and preserves Vaximm's ownership of VXM01 IP. An optional blockchain-based TAC token royalty mechanism is described if Vaximm uses BCM Royalty Fund capital.

3 months ago

#OSRH Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones

www.stocktitan.net/news/OSRH/vaximm-ag-an-o...

0 0 0 0

4 months ago

#OSRH OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study

www.stocktitan.net/news/OSRH/osr-holdings-a...

0 0 0 0

OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care BELLEVUE, Wash., Oct. 14, 2025/ PRNewswire/-- OSR Holdings, Inc. today announced that it has executed a definitive agreement to acquire Woori IO Co., Ltd., a pioneer in noninvasive glucose monitoring, via a comprehensive share exchange. WORIO shareholders will receive newly issued OSRK shares worth KRW15bn in exchange for WORIO shares. If, within 3 years of the share...

5 months ago

#OSRH OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care

www.stocktitan.net/news/OSRH/osr-holdings-s...

0 0 0 0

Below $1: OSR Holdings Faces Nasdaq Compliance Challenge While Investigating Unusual Trading Patterns Biotech firm OSR Holdings must meet $1 minimum bid price by March 2026 to maintain Nasdaq listing. Company highlights unusual trading patterns, elevated FTD data while advancing immunotherapy programs.

6 months ago

#OSRH OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity

www.stocktitan.net/news/OSRH/osr-holdings-r...

0 0 0 0

6 months ago

🚀 Exciting times for #OSRH! Trading at $0.80, it's showing potential upward momentum with a 10-day SMA of $0.70 and 20-day EMA of $0.73. Speculative trading hints at a short squeeze, but caution is key. Consider a long position at $0.78, targeting $0.85 & $0.90. 📈 #FeetrAI

0 0 0 0

6 months ago

🚀 Exciting times for #OSRH! Trading at $0.80, it's showing bullish signs with a MACD crossover and potential upward momentum. But watch out for legal news! Consider a cautious long position: entry at $0.78, target $0.90-$1.00, stop loss at $0.70. Stay tuned! 📈 #FeetrAI

0 0 0 0

6 months ago

🚀 Exciting times for #OSRH! Trading at $0.80, it's showing consolidation with a bullish MACD hint. Watch for a breakout above $0.82, targeting $0.85 & $0.88! 📈 Set stop loss at $0.76. Stay alert for market shifts and news! #StockMarket #FeetrAI #InvestSmart

0 0 0 0

6 months ago

🚀 Exciting times for #OSRH! With a price surge to $0.8101, positive MACD, and increased volume, this stock is showing strong momentum. Consider entering around $0.80 with targets at $0.90 & $1.00. Stay sharp, set your stop loss at $0.75, and watch the market closely! 📈 #FeetrAI

0 0 0 0

6 months ago

🚀 Exciting times for #OSRH! Trading at $0.85, this volatile gem shows bullish momentum with a 10-day SMA of $0.65 and an 8-day EMA of $0.75. 📈 RSI hints at overbought, but a short squeeze could push it to $0.90 or even $0.95! 🎯 Caution advised, but potential gains await! #FeetrAI

0 0 0 0

6 months ago

🚀 Exciting times for #OSRH! With a new eco-friendly product line and acquisition on the horizon, potential upside is brewing. 📈 Consider entering at $0.70 with targets at $0.85 & $1.00. Stay cautious of volatility, but the green wave could be worth the ride! 🌿💼 #FeetrAI

0 0 0 0

@stockmaster70.bsky.social

6 months ago

🚀 Exciting times for #OSRH! With a breakthrough in renewable tech and potential major partnership, bullish momentum is strong. 📈 RSI suggests caution, but MACD supports upward movement. Consider entry at $0.84, targeting $0.90 & $0.95. Stay vigilant! #Stocks #FeetrAI

0 0 0 0

Stock Master

6 months ago

📢 Stocks Trending NOW: #OPEN #INTC #BABA #PDD #STSS #CRCL #OSRH #COIN #ASST #OPAD

1 0 0 0

HumanAlgoHybrid

@humanalgohybrid.bsky.social

6 months ago

Top after-hours breakouts in stocks for Friday, August 22, 2025 sorted by range are $AYRO $9.36 (32%), $MRM $2.59 (46%), $SHFS $3.01 (6%), $ZONE $4.91 (2%) #OSRH #chartanalysis #stockmarket #daytrading

0 0 0 0

OSR Holdings Provides Transparency Update on Equity Financing Instruments OSR Holdings (NASDAQ: OSRH) has provided a detailed update on its equity financing instruments, particularly focusing on its Equity Line of Credit (ELOC) agreement with White Lion GBM Innovation Fund. The company has issued 2,308,382 total shares under structured financing, including 519,481 commitment shares, 745,193 convertible notes, and 276,208 warrant exercises.Under the ELOC agreement, which has a registered share capacity of 9,500,000, only 767,500 shares have been issued since June 17, 2025, representing less than 10% utilization. The company emphasized that proceeds are being invested in their drug R&D pipeline, medical device initiatives, and digital asset ecosystems.Additionally, OSRH revealed that Woori IO's clinical trial in Korea is being conducted in partnership with a major technology company in mobile and wearable devices, with the Stock Purchase Agreement expected to complete by October.

7 months ago

#OSRH OSR Holdings Provides Transparency Update on Equity Financing Instruments

www.stocktitan.net/news/OSRH/osr-holdings-p...

0 0 0 0

OSR Holdings Unveils Game-Changing Noninvasive Glucose Monitor Deal: $40B Market Opportunity Ahead Strategic acquisition brings needle-free glucose monitoring tech with Samsung backing. Learn how OSR Holdings plans to disrupt the $40B diabetes care market. See details.

7 months ago

#OSRH OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure

www.stocktitan.net/news/OSRH/osr-holdings-p...

0 0 0 0

Revolutionary Needle-Free Glucose Monitor Acquisition: OSR Holdings Targets Samsung-Backed Diabetes Tech Pioneer Breakthrough acquisition targets $40B diabetes tech market with needle-free glucose monitoring. Samsung-backed technology eliminates finger pricks. See deal details.

7 months ago

#OSRH OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology

www.stocktitan.net/news/OSRH/osr-holdings-e...

0 0 0 0

OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG OSR Holdings (NASDAQ:OSRH) has unveiled plans for a $50 million security token offering (STO) under Regulation D in H2 2025. The company will launch OSRT, a security token representing OSRH equity exposure, accepting Bitcoin (BTC), Tether (USDT), and Taekwondo Access Credit (TAC) as subscription currencies.The initiative is part of OSRH's broader strategy to build a $100 million Bitcoin and USDT reserve, supported by an $80 million equity line of credit (ELOC) from White Lion GBM Innovation Fund. BCM Europe AG, OSRH's largest shareholder, will convert its TAC holdings to BTC/USDT before participating in the offering to ensure compliance and avoid insider trading concerns.

8 months ago

#OSRH OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG

www.stocktitan.net/news/OSRH/osr-holdings-a...

0 0 0 0

OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG OSR Holdings (NASDAQ: OSRH) has unveiled plans for a $50 million security token offering (STO) under Regulation D in the second half of 2025. The company will launch OSRT, a security token representing equity exposure, accepting Bitcoin (BTC), Tether (USDT), and Taekwondo Access Credit (TAC) as subscription currencies.The strategic roadmap includes restrictions on BCM Europe AG, OSR's largest shareholder, from directly using TAC for subscription. The company aims to build a $100 million Bitcoin and USDT reserve, supported by both the STO and an $80 million equity line of credit (ELOC) from White Lion GBM Innovation Fund. This initiative aligns with OSR's blockchain-based capital strategy and its focus on integrating decentralized finance with healthcare innovation.

8 months ago

#BLAC #OSRH OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG

www.stocktitan.net/news/BLAC/osr-holdings-a...

0 0 0 0

OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token OSR Holdings (NASDAQ: OSRH) has signed a Memorandum of Understanding (MOU) with BCM Europe AG and Taekwondo Cooperative (TKD Coop) to develop a security token called the "OSRH Token". The token will accept Bitcoin (BTC), Tether (USDT), and Taekwondo Access Credit (TAC) as subscription currencies.The initiative aims to enhance crypto-based liquidity access and launch crypto treasury strategies. BCM Europe AG, OSRH's largest shareholder, intends to contribute its TAC token rights, reserve, and infrastructure to OSRH. TKD Coop, which has been using the TAC token since 2021, will continue leading blockchain adoption in the Taekwondo community. The MOU has a three-month term for finalizing the legal and technical framework.

9 months ago

#BLAC #OSRH OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token

www.stocktitan.net/news/BLAC/osr-holdings-b...

0 0 0 0